The short version
- Why people research itMitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- What the evidence isNone, and the zero is the finding.
- What to watchJoint pain, rash or autoimmune flare.
How Timusamin works
The manufacturer's own research group has published what it thinks the thymus extract actually is, and it changes what an oral version of it would have to achieve. Linkova 2023 names KE and EW — two dipeptides — as the active substances of the thymus drug.
And that question has a real literature, which is unusual for anything on this shelf. Khavinson 2023 assessed the feasibility of transporting 26 biologically active ultrashort peptides through the peptide transporters PEPT1 and PEPT2. Those are genuine, well-characterized intestinal and renal carriers whose physiological job is moving di- and tripeptides across an epithelium; they are the reason certain peptide drugs are orally active at all.
The manufacturer's own 2023 paper states that the active substances of the injectable thymus drug are two dipeptides, KE and EW — both of which are sold separately, on this same site, as defined compounds with their own pages.
- Oral
On the goal map: Thymus & immune (Organ-specific bioregulation)
Research on Timusamin5 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Evidence on file: No published study of this product. The literature belongs to the parenteral extracts and the synthetic peptides of the same school.
Human clinical evidence
None, and the zero is the finding. A PubTator3 search of PubMed for this product's name, run 8 September 2026, returned zero records — no trial, no case series, no pharmacokinetic study, no adverse-event report. A search for the class word *cytamins* returns exactly one record, a Russian nutrition review that lists them among categories of bioactive substances for liver disease. There has never been a setting in which a result of any kind could have been recorded for this tablet, which is a different statement from a clean record.
No completed human trial
Correlative data
The thymus extract Thymalin, given parenterally, carries the oldest human claims in this school — an immune-response report in vaccinated subjects in a 1988 Soviet military medical journal (Degtiarev 1988) and immune-status regulation in severely ill older patients (Kuznik 2021). Different product, different route, and an evidentiary standard set by the era it was published in.
The manufacturer's own 2023 paper says the drug is two dipeptides — KE and EW — both of which are sold separately on this site as defined compounds (Linkova 2023).
How the mechanism reads
That dipeptide finding turns the oral question into a specific one: di- and tripeptides have a named carrier route across the intestinal wall through PEPT1 and PEPT2, and the school has assessed transport feasibility for 26 of its own ultrashort peptides (Khavinson 2023).
MechanisticWhich points somewhere awkward for this product: the defined dipeptides are the version whose absorption can be reasoned about, and the extract is the version whose cannot.
Mechanistic
Sources
- Khavinson VKh, Cherniak SI, D'iakonov MM. [Cytamines--preparations for maintaining high professional ability and longevity in servicemen]. Voenno-Meditsinskii Zhurnal 2001 [Russian] · PMID 11338817
- Emirova LR, Rozhkova EA, Paniushkin VV, Mirzoian RS, Seifulla NR. [The effects of cytamines and their combinations with ecdystene, apilak, vitamax, and essentiale on the work capability of athletes]. Eksperimental'naia i Klinicheskaia Farmakologiia 2004 [Russian] · PMID 15341074
- Ryzhak GA, Nekrasov PA, Kiselev OI, Khavinson VKh. Study of protein components of natural peptide regulators. Bulletin of Experimental Biology and Medicine 2003 · PMID 12717513
- Rozhkova EA, Ordzhonikidze ZG, Druzhinin AE, Seifulla NR, Paniushkin VV, Kuznetsov IuM. [Using carnosine and natural antioxidants for the prophylaxis of acute post-loading oxidative stress]. Eksperimental'naia i Klinicheskaia Farmakologiia 2007 [Russian] · PMID 18074807
- Linkova N. The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19. International Journal of Molecular Sciences 2023 · PMID 37686182
- Khavinson VK, Linkova NS, Rudskoy AI, Petukhov MG. Feasibility of Transport of 26 Biologically Active Ultrashort Peptides via LAT and PEPT Family Transporters. Biomolecules 2023;13(3):552 · PMID 36979488
- Khavinson VKh, Malinin VV, Chalisova NI, Grigor'ev EI. [Tissue-specific action of peptides in tissue culture of rats of various ages]. Advances in Gerontology 2002;9:95-100 [Russian] · PMID 12096446
- Ryzhak AP, Chalisova NI, Lin'kova NS, Khalimov RI, Ryzhak GA, Zhekalov AN. [Polypeptides influence on tissue cell cultures regeneration of various age rats]. Advances in Gerontology 2015;28(1):97-103 [Russian] · PMID 26390619
- Degtiarev AA. Use of thymalin in stimulating an immune response in subjects inoculated with influenza vaccine. Voenno-Meditsinskii Zhurnal 1988 [Russian] · PMID 3206835
- Kuznik B, Khavinson V, Shapovalov K, Linkova N, Lukyanov S, Smolyakov Yu, Tereshkov P, Shapovalov Yu, Konnov V, Tsybikov N. Peptide Drug Thymalin Regulates Immune Status in Severe COVID-19 Older Patients. Advances in Gerontology 2021;11(4):368–376
- Khavinson VKh, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinology Letters 2003;24(3-4):233–240 · PMID 14523363
- Tokaev ES. [Bioactive substance used for treatment and preventive maintenance of liver diseases]. Voprosy Pitaniia 2007 [Russian] · PMID 17802767
Timusamin safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Anti-rejection drugs after transplant: an immune extract could raise rejection risk.
- Active autoimmune disease: a thymus fraction could flare it.
- Allergy to animal protein: it is from animal thymus.
- Pregnancy: a thymus extract could shift maternal immune tolerance.
What’s expected
- Probably nothing noticeable; no study of this tablet exists.
- Mild stomach upset while using Timusamin.
- Its stated active parts are the KE and EW dipeptides, which are sold separately as defined compounds.
Watch for
- Joint pain, rash or autoimmune flare.
- Persistent fever.
- Hives or wheeze.
- Swollen lymph glands.
Labs that tell you it’s working
- Complete Blood Count (CBC) w/ Differential
- hs-CRP (C-Reactive Protein, High Sensitivity)
- ESR (Sed Rate, Westergren)
- Vitamin D (25-Hydroxy)
Animal thymus fraction whose maker names the dipeptides KE and EW as active; lymphocyte and inflammation labs are the check.
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Timusamin FAQ4 common questions
- Is Timusamin approved for human use?
- No. Timusamin is a research compound. No completed randomized human trial has given it yet.
- What is Timusamin researched for?
- Mitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- Which labs show whether it's doing anything?
- Complete Blood Count; hs-CRP; ESR; Vitamin D: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Timusamin: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



